跳至主導覽
跳至搜尋
跳過主要內容
國立陽明交通大學研發優勢分析平台 首頁
English
中文
首頁
人員
單位
研究成果
計畫
獎項
活動
貴重儀器
影響
按專業知識、姓名或所屬機構搜尋
醫學系神經學科
醫學院
醫學系
概覽
指紋
網路
人員
(1)
研究成果
(516)
指紋
查看啟用 醫學系神經學科 的研究主題。這些主題標籤來自此機構會員的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Keyphrases
Acute Ischemic Stroke
11%
Aging Studies
6%
Alzheimer's Disease
100%
Alzheimer's Disease Patient
30%
Amnestic Mild Cognitive Impairment (aMCI)
20%
Anxiety Scale
6%
Apolipoprotein E
13%
Caregivers
11%
Cerebral Microbleeds
9%
Cerebral Small Vessel Disease (cSVD)
13%
Chinese Population
10%
Chinese Version
13%
Chronic Headache
22%
Chronic Migraine
40%
Clinical Dementia Rating
7%
Clinical Features
7%
Clinical Outcomes
7%
Clinical Practice Guidelines
7%
Cluster Headache
26%
Cognitive Decline
9%
Cognitive Function
18%
Cognitive Impairment
18%
Cognitive Performance
12%
Cognitive Screening
13%
Cognitively Normal
7%
Community-based Study
9%
Comorbidity
11%
Confidence Interval
29%
Consecutive Patients
7%
Dementia
43%
Dementia Risk
6%
Depressive Disorder
7%
Depressive Symptoms
6%
Diffusion Tensor Imaging
7%
Dynamic Cerebral Autoregulation
7%
Epidural Blood Patch
6%
Episodic Migraine
11%
Fibromyalgia
7%
Functional Connectivity
7%
Functional Outcome
6%
Gray Matter Volume
9%
Hazard Ratio
6%
Headache
60%
Headache Clinic
6%
Headache Disorders
6%
Healthy Controls
18%
High Risk
10%
Hypertension
7%
International Classification of Headache Disorders
8%
Intracerebral Hemorrhage
6%
Intracranial Hypotension
23%
Intravenous Thrombolysis
10%
Ischemic Stroke
28%
Jugular Venous Reflux
6%
Kinmen
11%
Magnetic Mismatch Negativity (MMNm)
6%
Magnetic Resonance Imaging
10%
Magnetoencephalography
11%
Major Depressive Disorder
15%
Medication Overuse Headache
8%
Migraine
76%
Migraine Attack
9%
Migraine Disability Assessment
9%
Migraine Patients
18%
Migraine without Aura (MWoA)
9%
Mild Alzheimer's Disease
7%
Mild Cognitive Impairment
34%
Mini-Mental State Examination
18%
Moderate to Severe
8%
National Cohort Study
28%
Nationwide Survey
8%
Neuropsychiatric Inventory Questionnaire (NPI-Q)
8%
Non-demented
7%
Normal Aging
6%
Odds Ratio
16%
Older Adults
8%
Older Men
6%
Oxime
8%
Parkinson Patients
6%
Parkinson's Disease
12%
Pathophysiology
9%
Physio-cognitive Decline Syndrome
6%
Placebo
7%
Plasma Amyloid-β
9%
Population-based Study
8%
Quality of Life
6%
Resting State
6%
Reversible Cerebral Vasoconstriction Syndrome
21%
Risk Factors
13%
Screening Tool
6%
Single-photon Emission Computed Tomography (SPECT)
11%
Subjective Cognitive Decline
6%
Symptomatic Intracerebral Hemorrhage (sICH)
7%
Taipei
7%
Taiwan
95%
Taiwanese
29%
Tau Levels
6%
Tension-type Headache
6%
Thunderclap Headache
12%
Total tau
8%
Neuroscience
Alzheimer's Disease
93%
Amyloid Protein
8%
Apolipoprotein E
8%
Auras
9%
Behavior (Neuroscience)
7%
Blood Plasma
22%
Brain Disease
6%
Brain Ischemia
43%
Cerebral Autoregulation
9%
Cerebral Hemorrhage
14%
Cerebrovascular Accident
44%
Cerebrovascular Disease
17%
Clinical Dementia Rating
8%
Cluster Headache
24%
Cognitive Disorders
28%
Cognitive Function
34%
Cognitive Tests
5%
Comorbidity
12%
Computed Tomography
5%
Cortical Excitability
6%
Depressive Disorder
6%
Diffusion Tensor Imaging
7%
Executive Function
6%
Fibromyalgia
7%
Functional Connectivity
6%
Functional Magnetic Resonance Imaging
7%
Gray Matter
11%
Gray Matter Volume
12%
Headache
99%
Hippocampus
6%
Hypertension
10%
Internal Carotid Artery
5%
Ischemia
5%
Lacune
5%
Longitudinal Study
9%
Magnetic Resonance Imaging
16%
Magnetic Resonance Imaging
16%
Magnetoencephalography
5%
Major Depressive Disorder
14%
Medication Overuse
10%
Middle Cerebral Artery
7%
Migraine
92%
Mild Cognitive Impairment
41%
Myocardial Infarction
5%
Oxime
8%
Parkinson's Disease
16%
Single-Photon Emission Computed Tomography
13%
Somatics
6%
Statistical Parametric Mapping
5%
Stenosis
5%
Subdural Hematoma
5%
Subjective Cognitive Decline
6%
Ultrasonography
6%
Vascular Disease
5%
Medicine and Dentistry
Alzheimer's Disease
34%
Amyloid Protein
6%
Apoplexy
30%
Blood Clot Lysis
7%
Brain Ischemia
21%
Cerebral Hemorrhage
9%
Cerebrospinal Fluid
5%
Cerebrovascular Disease
10%
Chronic Daily Headache
7%
Climacterium
6%
Cluster Headache
11%
Cognitive Defect
6%
Cognitive Function
10%
Cohort Analysis
14%
Combination Therapy
7%
Comorbidity
7%
Computer Assisted Tomography
5%
Diseases
8%
Epidural Blood Patch
5%
Frailty
6%
Hazard Ratio
9%
Headache
54%
Hemodynamic
5%
Intracranial Hypotension
21%
Magnetic Resonance Imaging
12%
MIDAS (Migraine)
5%
Middle Age
7%
Migraine
49%
Mild Cognitive Impairment
8%
Mini-Mental State Examination
5%
Odds Ratio
7%
Patient with Alzheimer's Disease
17%
Placebo
7%
Prevalence
14%
Prophylaxis
8%
Quality of Life
6%
Radioisotope
5%
Reversible Cerebral Vasoconstriction Syndrome
10%
Single-Photon Emission Computed Tomography
8%
Tension Headache
5%
Thunderclap Headache
10%
Transformed Migraine
17%